Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States
Authors
Keywords
Immunotherapy, Chemotherapy, Electronic health records, Bladder cancer, Advanced urothelial carcinoma
Journal
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-12-12
DOI
10.1016/j.urolonc.2021.11.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
- (2020) Matthew D Galsky et al. LANCET
- LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361
- (2020) A. Alva et al. ANNALS OF ONCOLOGY
- Clinical evidence for the first-line treatment of advanced urothelial carcinoma: Current paradigms and emerging treatment options
- (2020) Maria Koufopoulou et al. CANCER TREATMENT REVIEWS
- Sequencing of PD-1/L1 Inhibitors and Carboplatin-Based Chemotherapy for Cisplatin-Ineligible Metastatic Urothelial Carcinoma
- (2020) Xiao X. Wei et al. JOURNAL OF UROLOGY
- Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
- (2020) Thomas Powles et al. LANCET ONCOLOGY
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
- (2020) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment patterns and overall survival in metastatic urothelial carcinoma in a real-world, US setting
- (2019) Jason C. Simeone et al. Cancer Epidemiology
- Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer
- (2019) Emily Feld et al. EUROPEAN UROLOGY
- Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies
- (2018) Pedro C. Barata et al. Targeted Oncology
- Recent developments in the treatment of advanced bladder cancer
- (2018) James Luke Godwin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Immune Checkpoint Inhibition in Metastatic Urothelial Cancer
- (2017) Tom Powles et al. EUROPEAN UROLOGY
- Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
- (2017) Arlene Siefker-Radtke et al. Nature Reviews Urology
- Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
- (2011) M. D. Galsky et al. ANNALS OF ONCOLOGY
- Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
- (2011) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
- (2011) Maria De Santis et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started